The combination of lamivudine/dolutegravir is effectiveness in the treatment of HIV-1
As follows from the results of a study recently published in the journal Lancet, lamivudine / doloutegravir combination therapy demonstrated satisfactory efficacy, safety, and tolerability in treating people with HIV-1.